Error message

Notice: Undefined index: formatted_timezone in theme_date_display_combination() (line 158 of /data/crossleylab.unsw.edu.au/www/sites/all/modules/contrib/date/date.theme).
Adipokines and insulin action: A sensitive issue. Adipocyte. 2014 Apr 1;3(2):88-96. doi: 10.4161/adip.27552. Epub 2014 Jan 8. Review.
Author: 

Knights AJ, Funnell AP, Pearson RC, Crossley M, Bell-Anderson KS.

Key Summary: 

Obesity is a major public health concern and a strong risk factor for insulin resistance, type 2 diabetes mellitus (T2DM), and cardiovascular disease. The last two decades have seen a reconsideration of the role of white adipose tissue (WAT) in whole body metabolism and insulin action. Adipose tissue-derived cytokines and hormones, or adipokines, are likely mediators of metabolic function and dysfunction. While several adipokines have been associated with obese and insulin-resistant phenotypes, a select group has been linked with insulin sensitivity, namely leptin, adiponectin, and more recently, adipolin. What is known about these insulin-sensitizing molecules and their effects in healthy and insulin resistant states is the subject of this review. There remains a significant amount of research to do to fully elucidate the mechanisms of action of these adipokines for development of therapeutics in metabolic disease.